Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jumpei Kashima

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Seminars in Cancer Biology|May 15, 2022
Advances in biology and novel treatments of SCLC: The four-color problem in uncharted territoryJumpei Kashima, Yusuke Okuma
Case Reports in Oncology|September 12, 2024
Gingival Metastasis of ALK Rearranged Non-Small Cell Lung CancerRui Kitadai, Yusuke Okuma, Jumpei Kashima
BMC Cancer|March 21, 2018
Re-challenging immune checkpoint inhibitor in a patient with advanced non-small cell lung cancer: a case reportTaiki Hakozaki, Yusuke Okuma, Jumpei Kashima
Cancers|May 1, 2019
Molecular and Morphological Profiling of Lung Cancer: A Foundation for "Next-Generation" Pathologists and OncologistsJumpei Kashima, Rui Kitadai, Yusuke Okuma
Oncotargets and Therapy|October 28, 2016
A patient previously treated with ALK inhibitors for central nervous system lesions from ALK rearranged lung cancer: a case reportJumpei Kashima, Yusuke Okuma, Tsunekazu Hishima
Cancer Immunology, Immunotherapy : CII|December 16, 2017
High PD-L1 expression indicates poor prognosis of HIV-infected patients with non-small cell lung cancerYusuke Okuma, Tsunekazu Hishima, Jumpei Kashima, et al.
Cancer Immunology, Immunotherapy : CII|August 8, 2018
Correction to: High PD-L1 expression indicates poor prognosis of HIV-infected patients with non-small cell lung cancerYusuke Okuma, Tsunekazu Hishima, Jumpei Kashima, et al.
Oncology|September 19, 2019
High Serum Soluble CD27 Level Correlates with Poor Performance Status and Reduced Survival in Patients with Advanced Lung CancerJumpei Kashima, Yusuke Okuma, Yukio Hosomi, et al.
Journal of Cancer Research and Clinical Oncology|June 3, 2018
Survival analysis and pathological features of advanced non-small cell lung cancer with miliary pulmonary metastases in patients harboring epidermal growth factor receptor mutationsYusuke Okuma, Jumpei Kashima, Kageaki Watanabe, et al.
Japanese Journal of Clinical Oncology|January 9, 2017
Retrospective analysis of survival in patients with leptomeningeal carcinomatosis from lung adenocarcinoma treated with erlotinib and gefitinibJumpei Kashima, Yusuke Okuma, Maki Miwa, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Seminars in Cancer Biology|May 15, 2022
Advances in biology and novel treatments of SCLC: The four-color problem in uncharted territoryJumpei Kashima, Yusuke Okuma
Case Reports in Oncology|September 12, 2024
Gingival Metastasis of ALK Rearranged Non-Small Cell Lung CancerRui Kitadai, Yusuke Okuma, Jumpei Kashima
BMC Cancer|March 21, 2018
Re-challenging immune checkpoint inhibitor in a patient with advanced non-small cell lung cancer: a case reportTaiki Hakozaki, Yusuke Okuma, Jumpei Kashima
Cancers|May 1, 2019
Molecular and Morphological Profiling of Lung Cancer: A Foundation for "Next-Generation" Pathologists and OncologistsJumpei Kashima, Rui Kitadai, Yusuke Okuma
Oncotargets and Therapy|October 28, 2016
A patient previously treated with ALK inhibitors for central nervous system lesions from ALK rearranged lung cancer: a case reportJumpei Kashima, Yusuke Okuma, Tsunekazu Hishima
Cancer Immunology, Immunotherapy : CII|December 16, 2017
High PD-L1 expression indicates poor prognosis of HIV-infected patients with non-small cell lung cancerYusuke Okuma, Tsunekazu Hishima, Jumpei Kashima, et al.
Cancer Immunology, Immunotherapy : CII|August 8, 2018
Correction to: High PD-L1 expression indicates poor prognosis of HIV-infected patients with non-small cell lung cancerYusuke Okuma, Tsunekazu Hishima, Jumpei Kashima, et al.
Oncology|September 19, 2019
High Serum Soluble CD27 Level Correlates with Poor Performance Status and Reduced Survival in Patients with Advanced Lung CancerJumpei Kashima, Yusuke Okuma, Yukio Hosomi, et al.
Journal of Cancer Research and Clinical Oncology|June 3, 2018
Survival analysis and pathological features of advanced non-small cell lung cancer with miliary pulmonary metastases in patients harboring epidermal growth factor receptor mutationsYusuke Okuma, Jumpei Kashima, Kageaki Watanabe, et al.
Japanese Journal of Clinical Oncology|January 9, 2017
Retrospective analysis of survival in patients with leptomeningeal carcinomatosis from lung adenocarcinoma treated with erlotinib and gefitinibJumpei Kashima, Yusuke Okuma, Maki Miwa, et al.
Pageof 5